works perfectly
3 To understand the relationship between GLP-1 medications and kidney function, as measured by creatinine lab results, we studied 108,439 adult patients who started semaglutide, liraglutide, or tirzepatide between 2021 and 2024 and had one or more creatinine labs in the months leading up to and following the new medication
You should be especially cautious and speak with a provider if you have persistent nausea or vomiting, severe reflux, abdominal pain, a history of pancreatitis, gallbladder disease, liver disease, diabetes, low blood sugar episodes, frequent dehydration, a history of alcohol use disorder, alcohol withdrawal symptoms, or medications that should not be mixed with alcohol
Combination therapy requires attention to hydration status, kidney function, and risk of diabetic ketoacidosis during acute illness